Skip to main content
Fig. 3 | Journal of Nanobiotechnology

Fig. 3

From: A potential strategy against clinical carbapenem-resistant Enterobacteriaceae: antimicrobial activity study of sweetener-decorated gold nanoparticles in vitro and in vivo

Fig. 3

The antimicrobial ability of ASP_Au NPs in vitro and its core mechanism. A Growth curves of clinical CRE strains after treatment with different formulations. B Representative SEM images of clinical CRE strains after treatment with different formulations. C ROS levels in clinical CRE strains after treatment with different concentrations of formulations

Back to article page